Skip to main content
. Author manuscript; available in PMC: 2022 Oct 12.
Published in final edited form as: Gynecol Oncol. 2021 Aug 2;163(1):41–49. doi: 10.1016/j.ygyno.2021.07.016

Fig. 3.

Fig. 3.

Olaparib dose reductions in SOLO1 over time. Number of patients treated at the start of each month. *’Other Regimen’ includes 150 mg qd, 150 mg bid, 200 mg qd, 250 mg qd, 300 mg qd and 450 mg bid. †The category of ‘no dosing’ was assigned if the patient had dosing interrupted for the entire month window. bid, twice daily; qd, once daily.